iPS Cell Research Project for Regenerative Medicine - iPS細胞再生医療応用プロジェクト
  • Project details
  • News
  • Column
  • Research Support System
  • Links
  • Contact Us
  • Archive
  • English
    • 日本語 (Japanese)

size

  • Home
  • /News
  • /Research Activities
2014/1/17

High-throughput screening (HTS) leads to discovery of compounds that induce efficient differentiation of human iPS cells into nephrogenic cells.

A Kyoto University research team led by Associate Professor Kenji Osafune at CiRA has used a high-throughput compound screening system to identify substances that promote highly efficient differentiation of human iPS cells into intermediate mesoderm, from which the cells of the kidney, reproductive glands, and adrenal cortex originate.

 

As almost all kidney cells arise through differentiation from intermediate mesoderm, the essential step toward kidney regeneration is to develop technology for efficient differentiation of intermediate mesoderm from human iPS cells. By establishing a technology that performs efficient homologous gene recombination in human iPS/ES cells, the research team succeeded in introducing green fluorescent protein (GFP) into Odd-skipped related 1 (OSR1), which is a marker gene of intermediate mesoderm differentiation in human iPS cells, thus creating a system in which fluorescence can be used to confirm that cells have differentiated into intermediate mesoderm.

 

Using this system, the team searched for compounds that would induce highly efficient differentiation of iPS/ES cells into intermediate mesoderm and discovered two effective substances, the retinoids AM580 and TTNPB. This discovery should lead to the development of a reliable system for inducing differentiation of iPS/ES cells into kidney cells which will reduce cost compared to the conventional method using growth factors.

 

In the present research, a robotic system was used to screen a vast number of compounds for those which would be effective in inducing differentiation into intermediate mesoderm. Techniques using a robotic system of this kind have been widely used in drug discovery research.

 

Following the advent of iPS cells, attention is now focusing on the fact that they can also be used to research methods of inducing differentiation such as the present technique. Specifically, as growth factors and other proteins with human biological functions are high in cost and unstable as materials, they are not suitable for use on a large scale to induce differentiation. Going forward, it is expected that an important role will be played by a field known as chemical biology, in which cell status is controlled by low-molecular-weight compounds, which are lower in cost and materially more stable.

 

The research findings were published on January 15, 2014 (US Eastern time), in the online journal PLOS ONE.

 

20140117_3.png

Fig. Formation of renal tubule structures among cells derived from intermediate mesoderm

The cells which formed the tubular structures were positive for both LAMININ and LTL, suggesting that they were renal tubules.
Green: HuNu (i.e. human intermediate mesoderm-derived cells)
Red: LTL; Purple: LAMININ; Blue: nuclei; Scale bars: 100 µm.
 
<Journal Information>
Title of Paper
Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods
Authors
Toshikazu Araoka, Shin-ichi Mae, Yuko Kurose, Motonari Uesugi, Akira Ohta, Shinya Yamanaka, and Kenji Osafune

 

 

 Researchers develop method for generation and maintenance culture of human iPS cells suitable for use in cell transplantation
Method developed for using human iPS cells to create stable and large-scale supply of platelets
  • news
  • column
Transplantation of human iPS cell-derived glial-rich neural progenitor cells into ALS model mice extends their lifespans

A research group led by Dr. Haruhisa Inoue, a professor at the Center for iPS Cell Research and Application (CiRA), Kyoto University, and a researcher Dr. Takayuki Kondo of CiRA discovered that the transplantation of human iPS cell-derived glial-rich neural progenitor cells into amyotrophic lateral sclerosis (ALS) model mice extended their lifespans.   It is […]

2014/7/4 Read More
Human somatic cells pass through a primitive streak-like stage during reprogramming – Partial elucidation of the reprogramming mechanism –
2014/4/24 Read More
Study of the candidate factors responsible for the DNA demethylation required in iPS cell generation
2014/4/10 Read More
RSSRSS
12345Last »
 
No postings in this category.
 
Sitemap
  • Research Support System
  • Project details
  • News
  • Links
  • Contact Us
  • Column
  • Archive
CiRA
FIRST Funding Program for the World-Leading Innovative R&D on Science and Technology
Copyright © Center for iPS Cell Research and Application, Kyoto University. All rights Reserved.